Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Progesterone 200 mg Soft Capsule vs Utrogestan® in Healthy Females
NCT05125627Phase 1Completed
- Sponsor
- Farmak
- Start
- Aug 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of progesterone in Luteal phase deficiency (LPD) and preterm birth (2 arms), sponsored by Farmak. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve to Last Timepoint. Started Aug 2019; status: completed.
02
Drugs
progesterone
03
Conditions
Luteal phase deficiency (LPD)preterm birth
Beyond the preview
Go deeper on NCT05125627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05125627.